Skip to content

Clinical trials

Observational Amyloidosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Phase: Observational Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20141
20204
20213
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting2
Completed2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals3
Akcea Therapeutics1
AstraZeneca1
Charite University, Berlin, Germany1
European Society for Blood and Marrow Transplantation1
Heidelberg University1
Heinrich-Heine University, Duesseldorf1
Pfizer1
University Hospital Heidelberg1
University Hospital Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis13
Amyloid Neuropathies, Familial6
Amyloidosis, Familial3
Aortic Valve Stenosis3
Cardiomyopathies3
Polyneuropathies3
Amyloid Neuropathies2
Cardiomyopathy, Dilated2
Cardiomyopathy, Hypertrophic2
Immunoglobulin Light-chain Amyloidosis2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.